Medix Biochemica Oy

https://www.medixbiochemica.com

Medix Biochemica Group are a global, market-leading supplier of critical raw materials to the in vitro diagnostics (IVD) industry. Our mission is to enable IVD customers to deliver accurate results to billions of patients worldwide. By working in partnership with Medix Biochemica, IVD manufacturers can reduce their time to market through our industry-leading expertise which increases efficiencies and builds quality into their tests. We achieve this through our deep scientific know-how combined with the broadest and most relevant raw material portfolio and our relentless focus on quality. Medix Biochemica Group employs more than 240 professionals worldwide. With headquarters in Finland, we serve our worldwide customers through our local teams in the US, Europe, and Asia. *

	Start	1985-01-01 established
	Group	Medix Biochemica (Group)
	Industry	diagnostics (medical/biological)
	Industry 2	immunoassay (diagnostics, antibody-antigen-test)
	Person	Ferguson, Steve (Medix Biochemica 202201 CEO)

	Region	Espoo
	Country	Finland
	Street	3 Klovinpellontie
	City	02180 Espoo
	Tel	+358-9-547680
		Address record changed: 2022-02-01

Basic data	Employees	D: 101 to 500 (2022-02-01)

		* Document for »About Section«: Medix Biochemica Oy. (2/1/22). "Press Release: Medix Biochemica Expands Its Molecular Diagnostics Business through the Acquisition of myPOLS Biotec". Espoo.

		Record changed: 2024-02-12

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Medix Biochemica (Group)

[1] Medix Biochemica Oy. (2/1/22). "Press Release: Medix Biochemica Expands Its Molecular Diagnostics Business through the Acquisition of myPOLS Biotec". Espoo....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]